125 related articles for article (PubMed ID: 9378163)
21. Flow differences between endometrial polyps and cancer: a prospective study using intravenous contrast-enhanced transvaginal color flow Doppler and three-dimensional power Doppler ultrasound.
Lieng M; Qvigstad E; Dahl GF; Istre O
Ultrasound Obstet Gynecol; 2008 Dec; 32(7):935-40. PubMed ID: 19035544
[TBL] [Abstract][Full Text] [Related]
22. [Dynamic assessment of contrast medium enhancement in Doppler ultrasound imaging. Current status].
Huber S; Delorme S; Zuna I
Radiologe; 1998 May; 38(5):390-3. PubMed ID: 9646345
[TBL] [Abstract][Full Text] [Related]
23. B-mode, utero-ovarian and intratumoural transvaginal colour Doppler ultrasonography for differential diagnosis of ovarian tumours.
Mercé LT; Caballero RA; Barco MJ; Bau S; López G
Eur J Obstet Gynecol Reprod Biol; 1998 Jan; 76(1):97-107. PubMed ID: 9481556
[TBL] [Abstract][Full Text] [Related]
24. Differentiating between benign and malignant adnexal lesions with contrast-enhanced transvaginal ultrasonography.
Szymanski M; Socha MW; Kowalkowska ME; Zielińska IB; Eljaszewicz A; Szymanski W
Int J Gynaecol Obstet; 2015 Nov; 131(2):147-51. PubMed ID: 26254725
[TBL] [Abstract][Full Text] [Related]
25. Transvaginal color Doppler ultrasonography in the presurgical characterization of adnexal masses.
Caruso A; Caforio L; Testa AC; Ciampelli M; Panici PB; Mancuso S
Gynecol Oncol; 1996 Nov; 63(2):184-91. PubMed ID: 8910625
[TBL] [Abstract][Full Text] [Related]
26. Transvaginal color Doppler ultrasound for monitoring the response to neoadjuvant chemotherapy in advanced cervical cancer.
Greco P; Cormio G; Vimercati A; Nacci G; di Vagno G; Loverro G; Selvaggi L
Acta Obstet Gynecol Scand; 1997 Feb; 76(2):169-72. PubMed ID: 9049292
[TBL] [Abstract][Full Text] [Related]
27. Pre-operative assessment of benign and malignant ovarian tumours using colour Doppler ultrasonography.
Dasgupta S; Malty SP; Sharma PP; Mukhopadhyay A; Ghosh TK
J Indian Med Assoc; 2010 Aug; 108(8):495-7. PubMed ID: 21404744
[TBL] [Abstract][Full Text] [Related]
28. Gray scale sonography, subjective evaluation of the color Doppler image and measurement of blood flow velocity for distinguishing benign and malignant tumors of suspected adnexal origin.
Valentin L
Eur J Obstet Gynecol Reprod Biol; 1997 Mar; 72(1):63-72. PubMed ID: 9076424
[TBL] [Abstract][Full Text] [Related]
29. Does quantitative analysis of three-dimensional power Doppler angiography have a role in the diagnosis of malignant pelvic solid tumors? A preliminary study.
Testa AC; Ajossa S; Ferrandina G; Fruscella E; Ludovisi M; Malaggese M; Scambia G; Melis GB; Guerriero S
Ultrasound Obstet Gynecol; 2005 Jul; 26(1):67-72. PubMed ID: 15971296
[TBL] [Abstract][Full Text] [Related]
30. A combined Doppler and morphopathological study of ovarian tumors.
Kurjak A; Jukic S; Kupesic S; Babic D
Eur J Obstet Gynecol Reprod Biol; 1997 Feb; 71(2):147-50. PubMed ID: 9138957
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis of blood flow in breast tumors with increased blood pressure. New possibility in tumor field diagnosis].
Sohn C; Beldermann F; Frey H; Reinhardt S; Sohn J; Bastert G
Radiologe; 1997 Aug; 37(8):643-50. PubMed ID: 9411482
[TBL] [Abstract][Full Text] [Related]
32. Assessment of ovarian tumors using transvaginal color Doppler ultrasonography.
Daskalakis G; Kalmantis K; Skartados N; Thomakos N; Hatziioannou L; Antsaklis A
Eur J Gynaecol Oncol; 2004; 25(5):594-6. PubMed ID: 15493173
[TBL] [Abstract][Full Text] [Related]
33. Expression of thymidine phosphorylase in epithelial ovarian cancer: correlation with angiogenesis, apoptosis, and ultrasound-derived peak systolic velocity.
Hata K; Fujiwaki R; Maede Y; Nakayama K; Fukumoto M; Miyazaki K
Gynecol Oncol; 2000 Apr; 77(1):26-34. PubMed ID: 10739687
[TBL] [Abstract][Full Text] [Related]
34. Color Doppler assessment of blood flow in endometrial cancer.
Sawicki V; Spiewankiewicz B; Stelmachów J; Cendrowski K
Eur J Gynaecol Oncol; 2005; 26(3):279-84. PubMed ID: 15991526
[TBL] [Abstract][Full Text] [Related]
35. Colour and pulsed Doppler US and tumour marker CA 125 in differentiation between benign and malignant ovarian masses.
Antonić J; Rakar S
Anticancer Res; 1995; 15(4):1527-32. PubMed ID: 7654041
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of transvaginal color Doppler sonography, transvaginal sonography and CA 125 for prediction of ovarian malignancy.
Sengoku K; Satoh T; Saitoh S; Abe M; Ishikawa M
Int J Gynaecol Obstet; 1994 Jul; 46(1):39-43. PubMed ID: 7805982
[TBL] [Abstract][Full Text] [Related]
37. Benefits and limitations of ultrasonographic evaluation of uterine adnexal lesions in early detection of ovarian cancer.
Varras M
Clin Exp Obstet Gynecol; 2004; 31(2):85-98. PubMed ID: 15266758
[TBL] [Abstract][Full Text] [Related]
38. Three-dimensional ultrasonographic and power Doppler characterization of ovarian lesions.
Kurjak A; Kupesic S; Sparac V; Kosuta D
Ultrasound Obstet Gynecol; 2000 Sep; 16(4):365-71. PubMed ID: 11169314
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of ovarian tumor vascularization by means of intravaginal ultrasonography with color Doppler].
Szymański M; Sarap J; Szymański W; Grabiec M
Ginekol Pol; 1998 May; 69(5):298-302. PubMed ID: 9695331
[TBL] [Abstract][Full Text] [Related]
40. Comparison of transvaginal color Doppler imaging and color Doppler energy for assessment of intraovarian blood flow.
Tailor A; Jurkovic D; Bourne TH; Natucci M; Collins WP; Campbell S
Obstet Gynecol; 1998 Apr; 91(4):561-7. PubMed ID: 9540941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
